Evidence map›Paper›PMID 35066699›Full record

ArticleJournal of assisted reproduction and genetics2022

Whole-exome sequencing reveals new potential genes and variants in patients with premature ovarian insufficiency.

Ayberk Turkyilmaz, Ceren Alavanda, Esra Arslan Ates, Bilgen Bilge Geckinli, Hamza Polat, Mehmet Gokcu, Taner Karakaya, Alper Han Cebi, Mehmet Ali Soylemez, Ahmet İlter Guney and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of assisted reproduction and genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Ayberk TurkyilmazDepartment of Medical Genetics, School of Medicine, Karadeniz Technical University, Trabzon, Turkey. ayberkturkyilmaz@gmail.com.ORCID http://orcid.org/0000-0001-9647-8970
Ceren AlavandaDepartment of Medical Genetics, School of Medicine, Marmara University, Istanbul, Turkey.
Esra Arslan AtesDepartment of Medical Genetics, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Bilgen Bilge GeckinliDepartment of Medical Genetics, School of Medicine, Marmara University, Istanbul, Turkey.
Hamza PolatDepartment of Medical Genetics, School of Medicine, Marmara University, Istanbul, Turkey.
Mehmet GokcuDepartment of Medical Genetics, School of Medicine, Karadeniz Technical University, Trabzon, Turkey.
Taner KarakayaDepartment of Medical Genetics, Isparta City Hospital, Isparta, Turkey.
Alper Han CebiDepartment of Medical Genetics, School of Medicine, Karadeniz Technical University, Trabzon, Turkey.
Mehmet Ali SoylemezDepartment of Medical Genetics, School of Medicine, Marmara University, Istanbul, Turkey.
Ahmet İlter GuneyDepartment of Medical Genetics, School of Medicine, Marmara University, Istanbul, Turkey.
Pinar AtaDepartment of Medical Genetics, School of Medicine, Marmara University, Istanbul, Turkey.
Ahmet ArmanDepartment of Medical Genetics, School of Medicine, Marmara University, Istanbul, Turkey.
Marmara University · TRKaradeniz Technical University · TRIsparta University of Applied Sciences · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePremature ovarian insufficiency (POI) is a heterogeneous disorder characterized by the cessation of menstrual cycles before the age of 40 years due to the depletion or dysfunction of the ovarian follicles. POI is a highly heterogeneous disease in terms of etiology. The aim of this study is to reveal the genetic etiology in POI patients.

methodsA total of 35 patients (mean age: 27.2 years) from 28 different families diagnosed with POI were included in the study. Karyotype, FMR1 premutation analysis, single nucleotide polymorphism (SNP) array, and whole-exome sequencing (WES) were conducted to determine the genetic etiology of patients.

resultsA total of 35 patients with POI were first evaluated by karyotype analysis, and chromosomal anomaly was detected in three (8.5%) and FMR1 premutation was detected in six patients (17%) from two different families. A total of 29 patients without FMR1 premutation were included in the SNP array analysis, and one patient had a 337-kb deletion in the chromosome 6q26 region including PARK2 gene, which was thought to be associated with POI. Twenty-nine cases included in SNP array analysis were evaluated simultaneously with WES analysis, and genetic variant was detected in 55.1% (16/29).

conclusionIn the present study, rare novel variants were identified in genes known to be associated with POI, which contribute to the mutation spectrum. The effects of detected novel genes and variations on different pathways such as gonadal development, meiosis and DNA repair, or metabolism need to be investigated by experimental studies. Molecular etiology allows accurate genetic counseling to the patient and family as well as fertility planning.

Indexed as

Primary Ovarian InsufficiencyAdultChromosome AberrationsExome SequencingFemaleFragile X Messenger Ribonucleoprotein 1HumansKaryotypingMutationFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1FIGNL1Primary ovarian insufficiencySNP arrayWhole-exome sequencing

Identifiers

PMID35066699
PMCPMC8995228
OpenAlexW4207016981

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.